메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Park Jin Kyun (Division of Rheumatology Department of Internal Medicine Seoul National University College of Medic) Lee Eun Bong (Division of Rheumatology Department of Internal Medicine Seoul National University College of Medic) Shin Kichul (Division of Rheumatology Seoul Metropolitan Government-Seoul National University Boramae Medical Ce) Sung Yoon-Kyoung (Department of Rheumatology Hanyang University Hospital for Rheumatic Diseases Seoul Korea.) Kim Tae Hwan (Department of Rheumatology Hanyang University Hospital for Rheumatic Diseases Seoul Korea.) Kwon Seong-Ryul (Division of Rheumatology Department of Internal Medicine Rheumatism Center Inha University Hospital) Lee Myeung Su (Division of Rheumatology Department of Internal Medicine Wonkwang University Iksan Korea.) Hong Seung-Jae (Division of Rheumatology Department of Internal Medicine Kyung Hee University Hospital Seoul Korea.) Choi Byoong Yong (Department of Internal Medicine Seoul Medical Center Seoul Korea.) Lee Shin-Seok (Department of Rheumatology Chonnam National University Medical School & Hospital Gwangju Korea.) Back Han Joo (Division of Rheumatology Department of Internal Medicine Gachon University College of Medicine Gil)
저널정보
대한의학회 Journal of Korean Medical Science Journal of Korean Medical Science Vol.36 No.12
발행연도
2021.1
수록면
1 - 12 (12page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
The coronavirus disease 2019 (COVID-19) pandemic has caused more than 100 million infections and 2 million deaths worldwide. In up to 20% of cases, COVID-19 infection can take a severe, life-threatening course. Therefore, preventive measures such as mask-wearing, hand hygiene, and social distancing are important. COVID-19 vaccines that use novel vaccine technology can prevent up to 95% of infections. However, the uncertainty regarding the efficacy and safety of vaccination in patients with autoimmune inflammatory rheumatic disease (AIIRD), who are immunocompromised due to underlying immune dysfunction and concomitant immunosuppressive treatment, warrants clear guidance. A task force of the Korean College of Rheumatology formulated a set of vaccination guidance based on the currently available data and expert consensus. The currently available COVID-19 vaccines are considered to be safe and effective. Every patient with AIIRD should receive one of the available COVID-19 vaccines unless contraindicated for medical reasons such as prior allergy/anaphylaxis to the COVID-19 vaccine or its components. Patients should continue immunosuppressive treatment for their underlying AIIRD, including biological and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs). Corticosteroids should be reduced to the lowest dose possible without aggravating the AIIRD. To improve the vaccine response, methotrexate can be withheld for 1–2 weeks after each vaccination, and the timing of rituximab and abatacept infusion should be adjusted if clinically acceptable. Rheumatologists should play a leading role in educating and vaccinating patients with AIIRD.

목차

등록된 정보가 없습니다.

참고문헌 (62)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0